Cytokinetics | CYTK - Interest Expense On Debt

Stock Price
60.87
Daily Change
0.81 1.35%
Monthly
-8.63%
Yearly
35.54%
Q1 Forecast
58.25

Cytokinetics reported $30.33M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Amgen USD 653M 32M Dec/2025
Arca Biopharma USD 0 0 Mar/2025
Bayer EUR 675M 87M Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Capricor Therapeutics 581K 581K Dec/2024
Cytokinetics USD 30.33M 4.01M Dec/2025
Eisai JPY 1.43B 12M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Exelixis USD 23.4M 3.9M Sep/2023
Geron USD 7.3M 1.35M Dec/2025
Halozyme Therapeutics USD 4.91M 615K Dec/2025
Ionis Pharmaceuticals USD 18M 0 Dec/2025
Ligand Pharmaceuticals USD 910K 243K Sep/2025
Merck USD 412M 85M Dec/2025
Novartis USD 281M 8M Sep/2025
Pfizer USD 711M 59M Dec/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025